In cancer, the regulation of checkpoint pathways is often disrupted. This allows cells with damaged DNA to continue dividing, leading to genomic instability and the accumulation of mutations. The loss of checkpoint control is a hallmark of cancer and contributes to the uncontrolled growth and division of cancer cells. Therefore, understanding and targeting checkpoint pathways are critical for cancer treatment.
